STENO — StenoCare A/S Share News
0.000.00%
Last trade - 00:00- DKK47.30m
- DKK48.17m
- DKK7.02m
Brief: Stenocare Says Currently Offering New Shares At A Discounted Rate Of DKK 2.11 For To1 Warrant Owners
Brief: Stenocare Enters Into New Partnership Agreement With Quest Biotech Pharma
Brief: Stenocare Confirms Guidance, Reports Limited Capital Requirements
Brief: Australia To Become A Major Market For Stenocare In 2024
Brief: Stenocare Q3 EBITDA Widens To Loss Of DKK 3.8 Million
Brief: Stenocare: One-Off Return Of Products From Norway
Brief: Stenocare Preliminary Guidance For Q4-23 Is DKK 1.7 Mln
Brief: Stenocare Q2 EBITDA Loss Narrows To DKK 2.6 Mln
Brief: Stenocare Converts DKK 5.0 Mln Of Debt
Brief: Stenocare Q1 Loss per Share at 0.38
Brief: Stenocare Reports On Progress In Development Of New Product
Brief: Stenocare Product Gets Approved, Ready For Sale In Germany
Brief: Stenocare Announces Rights Issue Of Units Of Up To DKK 29.7 Mln
Brief: Stenocare FY Loss Widens To DKK 16.3 Mln
Brief: Stenocare On Track For Its Sales Expectations For 2023 In Range Of DKK 15-20 Mln
Brief: Stenocare Signs Distribution Agreement In Norway
Brief: Stenocare Gets Approval To Supply Danish Patients With New CBD Medical Cannabis Oil Product
Brief: Stenocare Q2 EBITDA Loss Widens To DKK 3.9 Mln
Brief: Stenocare Delivers First Product Batch To Danish Market